Metal-removing therapy may help some heart patients-study 
November 5th, 2012
By Deena Beasley and Bill Berkrot LOS ANGELES | Sun Nov 4, 2012 7:36pm EST LOS ANGELES (Reuters) – A controversial therapy to remove heavy metals from the bloodstream was shown in a large trial to cut the risk of another major heart problem in patients who have already suffered a heart attack, but researchers cautioned that the benefit was small and more study is needed. Chelation therapy, an alternative treatment dismissed by many medical professionals as quackery, has its origins in unproven 50-year-old theories about the cause of arterial plaques, the fatty deposits that can cause heart attacks.
[Continue Reading...]
Israel’s Neuronix offers new Alzheimer’s treatment
November 4th, 2012
By Tova Cohen TEL AVIV | Sun Nov 4, 2012 4:35am EST TEL AVIV (Reuters) – Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer’s disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014.
[Continue Reading...]
St Jude to cut 500 more jobs under realignment
November 1st, 2012
Thu Nov 1, 2012 7:47pm EDT (Reuters) – St Jude Medical Inc, a maker of heart devices, said it will cut 500 more jobs under its reorganization plan announced in August, when it realigned its business into two operating units and eliminated 300 jobs. It expects to incur additional pre-tax charges of about $40 million to $60 million related to the additional cuts, the company said in a regulatory filing on Thursday. The company has now slashed its global workforce by 5 percent and expects to incur total charges of between $150 million and $200 million through fiscal 2013
[Continue Reading...]
Ivermectin hair lotion found effective against lice
October 31st, 2012
By Gene Emery NEW YORK | Wed Oct 31, 2012 6:05pm EDT NEW YORK (Reuters Health) – A single 10-minute hair application of a drug used in oral form since the 1980s to control river blindness and other parasitic diseases eliminated head lice in nearly three of four children in a new study. The lotion contains ivermectin and is sold under the brand name Sklice by Sanofi Pasteur, which paid for the study. The U.S
[Continue Reading...]
Plant compounds tied to less stomach cancer in women: study
October 29th, 2012
Sun Oct 28, 2012 8:20pm EDT (Reuters) – Getting a moderate amount of plant substances called flavonoids through food may be linked to a lower stomach cancer risk in women – but not in men, according to a European study. The researchers, writing in the American Journal of Clinical Nutrition, found that women with the highest intake of flavonoids were half as likely to develop the disease as women who had the smallest intake. “A flavonoid-rich diet is based on plant-based foods (such as) fruits, vegetables, whole grain cereals, nuts, legumes, and their derived products (tea, chocolate, wine),” lead author Raul Zamora-Ros told Reuters Health by email
[Continue Reading...]
Trans fats raise cholesterol, not blood sugar
October 26th, 2012
By Kerry Grens NEW YORK | Fri Oct 26, 2012 2:03pm EDT NEW YORK (Reuters Health) – Although trans fats raise your levels of “bad” cholesterol, they don’t appear to have lasting impacts on your blood sugar, according to a new review of the medical evidence.
[Continue Reading...]
Meds a good "first step" for treating alcoholism
October 26th, 2012
By Genevra Pittman NEW YORK | Fri Oct 26, 2012 10:16am EDT NEW YORK (Reuters Health) – Two drugs commonly used to treat alcoholism may be appropriate for people in different stages of recovery, a new analysis confirms – likely because they work differently in the brain. The drugs, acamprosate (marketed as Campral) and naltrexone (ReVia), are both non-addictive themselves and don’t make users sick when mixed with alcohol. So they’re a good first option for people struggling with alcohol dependence who are motivated to stop drinking but would like to avoid an inpatient program, researchers said
[Continue Reading...]
Study suggests lowering cholesterol earlier in life
October 25th, 2012
By Frederik Joelving NEW YORK | Thu Oct 25, 2012 3:50pm EDT NEW YORK (Reuters Health) – Teens and young adults may want to pay attention to their cholesterol levels instead of waiting until later, when there is less room for improvement, according to a new study. There is no ironclad proof that doing so would actually benefit anyone, and the idea that people under 35 should be screened for high cholesterol is controversial.
[Continue Reading...]
Israeli medical device offers new Alzheimer’s treatment
October 24th, 2012
By Tova Cohen TEL AVIV | Wed Oct 24, 2012 8:06am EDT TEL AVIV (Reuters) – Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer’s disease, expects the system to be approved by the U.S. Food & Drug Administration in late 2014
[Continue Reading...]
